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HADDOW (1948) and Green (1954) showed that the carcinogenic angular
polycyclic hydrocarbons were capable of both initiating and inhibiting the growth
of some tumours. The purpose of this paper is to describe an attempt to modify
the chemical structure of these compounds in such a way as to enhance their
inhibitory effect.
It was felt that the problems of designing chemicals capable of a degree of
differential destruction oftumour cells have much in common with those ofleather
technology. The dyeing ofleather depends, in the first place, on charge differences
between the dyestuff and the protein fibre to draw the reactants together and after
this, firm bonding occurs due to the interplay of short range forces, such as dipole
bonds, hydrogen bonds or van der Waals forces. Otto (1953), who was working
with anionic dyestuffs, concluded that in the formation ofbonds between aromatic
substances and protein fibres the simplest kind of bond, whiclh is the basis for all
interactions, is an attraction between dipoles. On the other hand, in work on
textile fibres, Derbyshire and Peters (1955) emphasised the importance of short
range non-polar forces between the dye and the material being dyed.
Ambrose, James and Lowick (1956), amongst others, have shown that the
tumour cell carries a greater degree of negative charge than normal cells of the
same type. This suggested that a cancer chemotherapeutic agent based on the
aromatic hydrocarbons would require a degree ofpositive charge (cationisation) to
enable the agent to approach the negatively charged tumour surface more closely,
and also a certain minimum planar area so that it would bond adequately with the
tumour cell receptors through short range forces. Such bonding requires the
molecules ofthe agent and the cell surface to come into close proximity and implies
a precise complementary shape for the reactants.
The relationship of chemical structure to carcinogenic properties of the
polycyclic hydrocarbons and benzacridines is well known (Badger, 1948; Laccas-
sagne, Buu-Hoi, Daudel and Zajdela, 1.956; Clayson, 1962). Pullman and
Pullman (1955) believed that the effect of substituents is to alter the overall
electronic pattern in the polycyclic hydrocarbons, and Laccassagne et al. (1956)
were of the same opinion in respect of the benzacridines.
The work of Albert, Goldacre and Phillips (1948) on the connection between
chemical structure and basic strength in nitrogen substituted aromatic bases and
the description of the relationship between antibacterial potency and the sum-
mation of multiple weak bonds in the acridine series (Albert, Ribbo and Burvill,
1949) led us to choose the aminobenzacridines for this investigation.
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The numbering of substituted benzacridines is in a state of considerable
confusion. In this paper we have adopted the system of ring numbering used in
Chemical Abstracts as shown in Fig. 1.
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MATERIALS AND METHODS
Biological test system
The Furth rat leukaemia and the Chester Beatty Research Institute-derived
Wistar rats have been described previously (Green and Shortridge, 1967). In
these experiments all rats inoculated with blood containing 750,000 white cells
from leukaemic animals died, without further treatment, from 9-16 days later
with naked eye evidence of leukaemia at post mortem. When a group of these
animals received an inoculation from the same sample of blood they almost
invariably died within 2 days of each other.
Preparation of solutions
The chemicals were dissolved or suspended in one or more of the following
vehicles:
1. 70% propylene glycol, 0*025M phosphate buffer pH 7-4.
showed this to be the most suitable for many compounds.)
2. Dry ground in normal saline.
3. 70% propylene glycol, 0-025M phosphate buffer pH 7*0.
4. 20% propylene glycol, pH 6-8.
5. Normal saline, pH 5.5.
6. 20% propylene glycol, pH 7*1.
7. Normal saline, pH 5.0.
(Experience
826AMINOBENZACRIDINES AND RAT LEUKAEMIA
Procedure
Groups of four or five compounds, including 7-aminobenz(c)acridine, were set
up with each group of control rats; 6-10 rats were used for each compound.
Except where it is stated otherwise, solutions were injected s.c. at a different
site on each occasion, beginning between the first and the fourth day following the
inoculation of the tumour. The chemicals were usually given daily up to 7 days
after inoculation. Thereafter, chemical treatment was continued in groups of
animals with high white cell counts in the peripheral blood but was withheld from
groups in which the counts were near normal. The magnitude of the dose was
determined by the amount of chemical available and its toxicity.
Many of the administered chemicals led to a s.c. reaction with local inflamma-
tion and oedema, followed in most cases by some ulceration of the skin.
Chemicals
All the benzacridine derivatives and related compounds were prepared in the
laboratory. 7-Aminobenz(c)acridine, 12-aminobenz(a)acridine, 9-aminobenz(c)-
acridine, 4-aminobenz(h)quinoline (Albert, Brown and Duewell, 1948), 10-amino-
benz(c)acridine (Albert, 1948), 7-N-(2'-hydroxyethyl)aminobenz(c)acridine (Els-
lager, Moore, Short, Sullivan and Tendick, 1957), 7-(3'-diethylaminopropylamino)-
benz(c)acridine hydrochloride, 7-chlorobenz(c)acridine (Bachman and Picha, 1946),
7-phenoxybenz(c)acridine (Moore, Elslager and Short, 1961) and 7-aminobenz(b)-
(1,10)phenanthroline (Wilkinson and Finar, 1948) had the same characteristics as
described in the previous literature.
New compounds were prepared (Table I) by various methods:
A. 7-(N-Alkylamino)-benz(c)acridines. To 7-phenoxybenz(c)acridine (0.01
mole) in phenol (20 g.) at 700 C. was added the appropriate amine hydrochloride
(0-01 mole) and the mixture heated to 1200 C. for 2 hours. The cooled solution
was poured into ether and stood at 40 C. overnight. The solid was dissolved in
methanol and reprecipitated with ether. It was extracted into water and the
product precipitated with alkali and crystallised from benzene-petroleum spirit.
B. 9-Methoxy-7-N-(2'-hydroxyethyl)aminobenz(c)acridine. 7-Chloro-9-meth-
oxybenz(c)acridine (Bachman and Picha, 1946) (5 g.) and ethanolamine (25 ml.)
were heated for 4 hours at 1200 C. The cooled mixture was added to acetone
(200 ml.) and kept at 40 C. overnight. Unreacted starting material was removed
by filtration and the product precipitated by the addition of ION HCI (50 ml.).
Crystallisation was induced by trituration with isopropanol. The residue was
extracted with water and the free base thrown out with 2N NaOH. Crystallisation
from ethanol gave the desired material (365 g., 65%).
C. 7-Amino-10-nitrobenz(c)acridine. 2-Chloro-4-nitrobenzoic acid and 1-
naphthylamine were reacted by the method of Lesnianski (1929) to give N-(1'-
naphthyl)-4-nitroanthranilic acid (m.p. >300° C., 46%). This with phosphoryl
chloride gave 7-chloro-10-nitrobenz(c)acridine (m.p. >300° C., 73%). To the
latter (0.01 mole) in phenol (40 g.) at 1200 C. was added powdered ammonium
carbonate (0-015 mole) over 10 minutes followed by further heating for 1 hour.
The product was precipitated by addition of the mixture to excess 2N NaOH and
finally crystallised from nitrobenzene.
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7-Amino-10-chlorobenz(c)acridine was similarly prepared from 7,10-dichloro-
benz(c)acridine (Elslager et al., 1957).
D. 7,9-Diaminobenz(c)acridine. N-(1'-Naphthyl)-5-nitroanthranilic acid
(Lesnianski, 1929) (0.094 mole, 29 g.) was refluxed with phosphoryl chloride
(500 ml.) for 2 hours. After the excess phosphoryl chloride had been distilled, the
residue was thinned with chloroform (200 ml.) and added to a large excess of
ammonia and ice to obtain 7-chloro-9-nitrobenz(c)acridine (m.p. 252-254° C.,
81%). This was converted into 7-amino-9-nitrobenz(c)acridine by method C
(m.p. >300° C., 97%). The latter (0-013 mole, 3*8 g.) was added portion-wise to
a stirred boiling solution of stannous chloride (0.055 mole) in ION HC1 (45 ml.).
Further ION HCI was added (20 ml.). The solution was stirred at 1000 C. for
2 hours, cooled and 30% NaOH (100 ml.) added. The precipitate was extracted
with hot 10% acetic acid (2 x 100 ml.) and a trace of sodium hydroxide solution
added to throw out black solid matter. Treatment of the filtered solution with
excess sodium hydroxide gave 7,9-diaminobenz(c)acridine which was crystallised
from benzene (m.p. 163-164° C., 53%).
E. 7-Acetamidobenz(c)acridine. The amine (0.01 mole) was heated with acetic
anhydride (12 ml.) for 0 5 hour at 100-1100 C. The solid was washed with benzene
and hot alcohol (m.p. >300° C., 81 %).
F. 7-(N-Alkylamino)-9-methoxybenz(c)acridines. These were made by method
A using 7-phenoxy-9-methoxybenz(c)acridine (obtained from 7-chloro-9-methoxy-
benz(c)acridine by reaction with phenol) as starting material.
G. 5-Ethyl-7-aminobenz(c)acridine. N-(4'-Ethyl-l'-naphthyl)anthranilic acid,
m.p. 177-9° C., was obtained from 4-ethyl-1-naphthylamine and 2-chlorobenzoic
acid by the Jourdan-Ullmann reaction (Bachman and Picha, 1946), yield 32%.
This was converted to 5-ethyl-7-chlorobenz(c)acridine, m.p. 125-1270 C. with
phosphoryl chloride, yield 33%. The amination was then performed by method C.
H. 7-(2'-Propanediol)aminobenz(c)acridine. 7-Chlorobenz(c)acridine (0.02
mole) was dissolved in phenol (40g.) at 700 C. I-Amino-2,3-propanediol (0.034
mole) was added and the mixture heated at 1200 C. for 3 hours. The cooled
solution was poured into acetone and the resulting solid dissolved in methanol and
reprecipitated with ether. An aqueous solution ofthis was made alkaline and the
thick oil obtained, crystallised from ethanol.
Chemicals were characterised by their melting point and elementary analysis
(Table I). U.V. spectra were determined on a Unicam S.P. 700 Recording
Spectrophotometer and I.R. spectra on a Perkin Elmer 257 Spectrophotometer.
pKa values were determined by the potentiometric titration method ofAlbert and
Serjeant (1962) using 0-0005 g. mole of the chemical in the solvents indicated in
Table I. These were corrected to the values to be expected in aqueous solution
by the method of Albert et al. (1949).
RESULTS AND COMMENT
The first series of experiments (Table II) demonstrated that 7-aminobenz(c)-
acridine was consistently and significantly effective in prolonging the life of rats
carrying the Furth leukaemia if it were administered on several occasions by s.c.
injection. Single injections or the compound in the diet were ineffective.
It appears that with these compounds four conditions must be satisfied at the
same time for anti-tumour activity: (i) the charge on the molecule, which is
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TABLE II.-Variation in the Method of Administration of 7-Aminobenz(c)-
acridine and Activity Against the Furth Rat Leukaemnia
% Increase in survival Dose of
Method of pH of over that of controls chemical
administration Frequency medium in separate experiments (mg.)
s.c. injection . multiple 7 97, 68, 45, 43 . 35-65
43, 63, 77, 55
s.c. injection . single >7 . 20, 35 15-25
s.c. injection multiple . <7 . 65, 42, 72 . 40-70
<5 . 0, 12 35-100
1 % in diet daily . 25
dependent on the pKa value; (ii) the distribution of this charge within the mole-
cule; (iii) the shape of the molecule which determines its fit on the receptor; and
(iv) the surface area ofthe molecule which determines the stability of combination
with the receptor. Thus, adequate ionisation is needed but is not sufficient in
itself because, although 7-aminobenz(c)acridine is active, the similarly ionised
12-aminobenz(a)acridine and 4-aminobenz(h)quinoline are without activity
(Table III). The critical importance ofcharge distribution is shown by comparing
the two former compounds. Similarly the shape of the molecule by itself is
inadequate as 7-chlorobenz(c)acridine has approximately the same spatial charac-
teristics as 7-aminobenz(c)acridine but is devoid of activity. Finally the area of
the molecule must exceed that of 4-aminobenz(h)quinoline or 9-aminoacridine.
Attempts to enhance the activity of 7-aminobenz(c)acridine have proved
unsuccessful. Only the 7-N-methyl and 7-N-ethyl derivatives have shown slight
and variable activity against the Furth leukaemia. Substitution of the 7-amino
group with n-propyl, n-butyl, 3'-diethylaminopropyl, 2'-hydroxyethyl or phenyl
led to inactive compounds. Similarly, ring substitution, as in 7,9- and 7,10-
diaminobenz(c)acridine, 7-amino-9-nitrobenz(c)acridine and 7-amino-10-chloro-
benz(c)acridine, led to inactive compounds. The aza substituted derivative,
7-aminobenz(b)(1,10)-phenathroline, and 7-phenoxybenz(c)acridine were also
without significant activity.
The acute toxicity of 7-aminobenz(c)acridine was assessed after subcutaneous
injection as LD50 = 22 mg./100 g. body weight. Administration of 6 daily doses
of 5 mg./100 g. body weight to 6 rats led to a loss in weight of 15% and reduction
in the total white cell count to 26% of the normal value. The white cell count
began to rise 4-5 days after the first dose and showed a marked neutrophilia.
Lymphocytes recovered more slowly. Further investigations should be directed
to preparing aminobenzacridines with a higher therapeutic ratio. Some of these
chemicals have been forwarded to European Organisation for Research onTreat-
ment of Cancer (GECA) for fuller investigation.
SUMMARY
1. Reasons have been advanced for the study of aminobenzacridines as
cancer therapeutic agents.
2. Of 20 compounds tested only one, 7-aminobenz(c)acridine, showed an
inhibitory effect on the test tumour, the Furth rat leukaemia.
We thank G. Littlewood, A.I.M.L.T., for the maintenance and treatment ofthe
animals and Professor D. B. Clayson for advice in the preparation of the manu-
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